For example, in breast cancer, only three genes (TP53, PIK3CA and GATA3) occur at > 10% incidence; for most tumor types, the current sample size is too small to reliably detect genes mutated at 5% or less above background mutation intensity [2]. This evidence concerns the gene PIK3CA and breast cancer.